Faculty Disclosures
| Christopher J. Boes, MD, FAAN |
Dr. Boes has nothing to disclose. |
| Joseph I. Sirven, MD, FAAN |
Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurona. Dr. Sirven has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN. Dr. Sirven has received publishing royalties from a publication relating to health care. Dr. Sirven has received personal compensation in the range of $10,000-$49,999 for serving as a Host/ Co producer with WJCT Public Media. Dr. Sirven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant with Federal Aviation Administration . |
| Douglas J. Lanska, MD, FAAN |
Dr. Lanska has received personal compensation for serving as an employee of Ministry of Health of the Russian Federation. Dr. Lanska has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MedScape 好色先生. Dr. Lanska has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink Neurology. Dr. Lanska has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Ebix/Oakstone Publishing. Dr. Lanska has received publishing royalties from a publication relating to health care. Dr. Lanska has received personal compensation in the range of $500-$4,999 for serving as a Invited speaker with Mayo Clinic. |
| Frank W. Drislane, MD, FAAN |
No disclosure on file
|
| Joseph F. Drazkowski, MD, FAAN |
Dr. Drazkowski has nothing to disclose. |
| George K. York III, MD, FAAN |
No disclosure on file
|
| Francisco Cardoso, MD, FAAN |
No disclosure on file
|
| Spencer G. Weig, MD |
No disclosure on file
|
|
No disclosure on file
|
| Calixto Machado, MD, PhD, FAAN |
Dr. Machado has nothing to disclose. |
| John Papatriantafyllou, MD |
Dr. Papatriantafyllou has nothing to disclose. |
| Farrah J. Mateen, MD, PhD, FAAN |
Dr. Mateen has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon Therapeutics (Amgen). Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Mateen has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Mateen has received research support from Genentech. The institution of Dr. Mateen has received research support from EMD Serono. The institution of Dr. Mateen has received research support from Novartis. The institution of Dr. Mateen has received research support from Horizon Therapeutics (Amgen). The institution of Dr. Mateen has received research support from TG Therapeutics. Dr. Mateen has received intellectual property interests from a discovery or technology relating to health care. |
| Fizel A. Al-Himyari, MD |
No disclosure on file
|
| Ylmar Correa Neto, MD |
No disclosure on file
|
| Corrado Angelini, MD, FAAN |
Dr. Angelini has nothing to disclose. |
| David A. Steinberg, MD |
No disclosure on file
|
| Katherine H. Noe, MD, PhD, FAAN |
Dr. Noe has a non-compensated relationship as a committe member, Epilepsy MOC article review pilot with American Board of Psychiatry and Neurology that is relevant to AAN interests or activities. |
| Mason M. Marks |
No disclosure on file
|
| Robert L. Marks, MD, FAAN |
No disclosure on file
|
| Steven A. Sparr, MD, FAAN |
Dr. Sparr has nothing to disclose. |
| Leonidas Stefanis, MD |
No disclosure on file
|
| Sokratis Papageorgiou, MD |
Dr. Papageorgiou has nothing to disclose. |
| Douglas W. Zochodne, MD |
No disclosure on file
|
| GURCHARANJEET KAUR, MBBS |
Dr. Kaur has nothing to disclose. |
| Agnes Kowalska, MD |
Dr. Kowalska has nothing to disclose. |
| Lindsay N. Alfano, PT |
Ms. Alfano has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ATOM International, Ltd (Amicus Therapeutics, Catabasis, Genethon, Italfarmaco, NS Pharma, Pfizer, PTC Therapeutics). Ms. Alfano has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sarepta Therapeutics. The institution of Ms. Alfano has received research support from Novartis Gene Therapies. The institution of Ms. Alfano has received research support from Sarepta Therapeutics. The institution of Ms. Alfano has received research support from Audentes Therapeutics/Astellas Gene Therapies. Ms. Alfano has received intellectual property interests from a discovery or technology relating to health care. |
| Ryna Then, MD |
Dr. Then has nothing to disclose. |
| Lauren A. Cameron, MD |
Dr. Cameron has nothing to disclose. |
| Fernanda Wajnsztajn, MD |
An immediate family member of Dr. Wajnsztajn has received personal compensation for serving as an employee of Alexion Pharmaceuticals. |